Arbutus Biopharma Corporation
Market Cap
$850.78M
P/E Ratio
-25.41
EPS
$-0.17
Dividend Yield
0.00%
52-Week Range
$2.94 — $5.10
Volume
775.87K
Avg Volume
2.36M
Beta
0.74
Get alerted when ABUS hits your target price.
Free — enter your email to get started
P/E (TTM)
-25.41
Forward P/E
—
PEG Ratio
-1.40
P/S (TTM)
61.91
P/B (TTM)
11.16
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.42%
ROA (TTM)
-0.35%
ROIC
—
Gross Margin
0.36%
Operating Margin
-3.49%
Net Margin
—
Debt/Equity
0.05
Current Ratio
15.73
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.18%
EPS Growth (5Y)
+0.28%
Sales Growth (3Y)
+0.45%
Sales Growth (5Y)
+0.42%
EPS Est (This Year)
$-0.16
EPS Est (Next Year)
$-0.05
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.48
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
0
Outstanding Shares
192.32M
Float
150.24M
Free Float %
78.12%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2007-07-26
Employees
44
CEO
Lindsay Androski
Index Membership
—
Website
https://www.arbutusbio.com
Arbutus Biopharma Corporation (ABUS) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $850.78M, a P/E ratio of -25.41, ABUS is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ABUS against other stocks using dozens of fundamental and technical filters.
Arbutus Biopharma Corporation (ABUS) has a trailing twelve-month (TTM) P/E ratio of -25.41. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Arbutus Biopharma Corporation (ABUS) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Arbutus Biopharma Corporation (ABUS) has a market capitalization of $850.78 million, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.